HK1040486A1 - 脂肪酸-抗癌共軛和其用途 - Google Patents

脂肪酸-抗癌共軛和其用途

Info

Publication number
HK1040486A1
HK1040486A1 HK02100653.6A HK02100653A HK1040486A1 HK 1040486 A1 HK1040486 A1 HK 1040486A1 HK 02100653 A HK02100653 A HK 02100653A HK 1040486 A1 HK1040486 A1 HK 1040486A1
Authority
HK
Hong Kong
Prior art keywords
fatty acid
conjugates
anticancer
anticancer conjugates
fatty
Prior art date
Application number
HK02100653.6A
Other languages
English (en)
Inventor
l webb Nigel
O Bradley Matthews
Anthony Forrest
Fisher Mark
Original Assignee
Luitpold Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/265,307 external-priority patent/US7235583B1/en
Application filed by Luitpold Pharm Inc filed Critical Luitpold Pharm Inc
Publication of HK1040486A1 publication Critical patent/HK1040486A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02100653.6A 1999-03-09 2002-01-28 脂肪酸-抗癌共軛和其用途 HK1040486A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/265,307 US7235583B1 (en) 1999-03-09 1999-03-09 Fatty acid-anticancer conjugates and uses thereof
US18615200P 2000-03-01 2000-03-01
PCT/US2000/006160 WO2000053231A2 (en) 1999-03-09 2000-03-09 Fatty acid-anticancer conjugates and uses thereof

Publications (1)

Publication Number Publication Date
HK1040486A1 true HK1040486A1 (zh) 2002-06-14

Family

ID=26881822

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100653.6A HK1040486A1 (zh) 1999-03-09 2002-01-28 脂肪酸-抗癌共軛和其用途

Country Status (10)

Country Link
EP (1) EP1163011A2 (zh)
JP (1) JP2002538224A (zh)
KR (1) KR20020000147A (zh)
CN (1) CN1377282A (zh)
AU (1) AU3733300A (zh)
CA (1) CA2366723C (zh)
CZ (1) CZ20013123A3 (zh)
HK (1) HK1040486A1 (zh)
RU (1) RU2001127313A (zh)
WO (1) WO2000053231A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
JP2005500988A (ja) * 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
ATE556706T1 (de) * 2001-03-23 2012-05-15 Luitpold Pharm Inc Fettalkohol-arzneimittel-konjugate
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
EP1509256B1 (en) 2002-05-24 2009-07-22 Angiotech International Ag Compositions and methods for coating medical implants
CA2529125A1 (en) * 2003-06-19 2004-12-23 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
AU2004285529A1 (en) * 2003-10-30 2005-05-12 The Research Foundation of University of New York York Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
EP1862183B1 (en) * 2005-03-14 2010-11-03 Otsuka Pharmaceutical Factory, Inc. Kit comprising drug and fat emulsion
KR100753112B1 (ko) * 2007-02-26 2007-08-29 (주)고려다이나믹스 카드 발권 시스템
BR112015000236A2 (pt) * 2012-07-10 2017-06-27 Baseclick Gmbh moléculas de ácidos nucleicos modificadas por anandamida
CN117088935A (zh) * 2022-05-20 2023-11-21 上海维洱生物医药科技有限公司 一种雷公藤甲素木蜡酸酯及其脂质体与制备方法
KR20230174082A (ko) * 2022-06-20 2023-12-27 (주) 바이오인프라생명과학 약물을 전달하기 위한 초음파 감응형 약물전달체를 생성하는 방법 및 이를 이용한 초음파 감응형 약물전달체
CN116676355B (zh) * 2023-08-03 2023-10-24 成都第一制药有限公司 一种催化合成山莨菪碱的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925327A (ja) * 1982-07-31 1984-02-09 Hidematsu Hirai 抗腫瘍性複合体の製造方法
CA2125279A1 (en) * 1991-12-10 1993-06-24 John Sayler Coon Methods and compositions for reducing multi-drug resistance
US5925669A (en) * 1994-03-22 1999-07-20 Molecular/Structural Bio Technologies, Inc. Carrier compositions for anti-neoplastic drugs
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
CA2255615C (en) * 1996-05-22 2006-08-29 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same

Also Published As

Publication number Publication date
CA2366723C (en) 2011-08-02
RU2001127313A (ru) 2003-09-20
AU3733300A (en) 2000-09-28
JP2002538224A (ja) 2002-11-12
CA2366723A1 (en) 2000-09-14
EP1163011A2 (en) 2001-12-19
KR20020000147A (ko) 2002-01-04
WO2000053231A3 (en) 2001-10-04
WO2000053231A2 (en) 2000-09-14
CN1377282A (zh) 2002-10-30
CZ20013123A3 (cs) 2002-03-13

Similar Documents

Publication Publication Date Title
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
IL183948A (en) Peg-urate oxidase conjugates and use thereof
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
HK1043936A1 (zh) 含有脂調節劑的新的配方
IL148247A (en) Vaccine and its uses
GB9903584D0 (en) Modified calycins
HK1044704A1 (zh) 含有脂調節劑的新配方
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HK1040486A1 (zh) 脂肪酸-抗癌共軛和其用途
EP1226154A4 (en) ÖSTRADIOL CONJUGATES AND ITS USE
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
EG22491A (en) Rest-breaking composition and use thereof
GB9922135D0 (en) Compositions and uses
HK1041832A1 (zh) 血紅蛋白-抗氧化劑輟合物
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
AU5979300A (en) Angiopoietin-6 and uses thereof
GB9929581D0 (en) Comjpositions and their use
GB9911606D0 (en) Composition and use
IL149638A0 (en) S-allylmercaptoglutathione and uses thereof
GB9916675D0 (en) Enigma-sip and enigma-cell
GB9914167D0 (en) Compositions and uses
TW382972U (en) Environmental protective and hygienic photoelectric censer

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: LUITPOLD PHARMACEUTICALS, INC.

Free format text: FORMER OWNER(S): PROTARGA INC

CHPA Change of a particular in the register (except of change of ownership)